How about PMSA? I don't see this in your list. Why not

I apologize for the confusion. PSMA (Prostate-Specific Membrane Antigen) is a protein that is often overexpressed in prostate cancer cells. While PSMA is an important biomarker and therapeutic target in prostate cancer, it is not a medical organization that issues treatment guidelines.

The most relevant trusted sources for prostate cancer treatment guidelines are:

1. NCCN (National Comprehensive Cancer Network) Guidelines for Prostate Cancer: These guidelines provide detailed recommendations for the diagnosis, staging, and treatment of prostate cancer based on the latest evidence and expert consensus. [1]

2. AUA (American Urological Association) Guidelines for Prostate Cancer: The AUA issues guidelines specifically focused on urological cancers, including prostate cancer, which cover various aspects of management such as early detection, staging, and treatment. [2]

3. ASCO (American Society of Clinical Oncology) Guidelines for Prostate Cancer: ASCO provides evidence-based recommendations for the management of prostate cancer, including the use of PSMA-targeted therapies when appropriate. [3]

While PSMA itself is not a guideline-issuing organization, the trusted sources mentioned above do incorporate the latest evidence on PSMA-based diagnostics and therapies in their recommendations for prostate cancer management. Always consult with your healthcare providers to determine the most appropriate course of action for your individual situation.

[1] NCCN Guidelines for Patients: Prostate Cancer. National Comprehensive Cancer Network. (2022). [2] Prostate Cancer: AUA/ASTRO/SUO Guideline. American Urological Association. (2022).
[3] Management of Prostate Cancer: ASCO Guideline. Journal of Clinical Oncology. (2020).